Cargando…

Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma is the second cause of cancer-related death worldwide. Of those advanced-stage patients who are treated with sorafenib, those who develop early dermatologic adverse events have a better prognosis. These events are possibly immune-related. Therefore, we analyz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corominas, Josep, Sapena, Victor, Sanduzzi-Zamparelli, Marco, Millán, Cristina, Samper, Esther, Llarch, Neus, Iserte, Gemma, Torres, Ferràn, Da Fonseca, Leonardo G., Muñoz-Martínez, Sergio, Forner, Alejandro, Bruix, Jordi, Boix, Loreto, Reig, María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865624/ https://www.ncbi.nlm.nih.gov/pubmed/33498698 http://dx.doi.org/10.3390/cancers13030426

Ejemplares similares

Early diarrhoea under sorafenib as a marker to consider the early migration to second‐line drugs
por: Díaz‐González, Álvaro, et al.
Publicado: (2021)

Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib
por: Sapena, Víctor, et al.
Publicado: (2022)

Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients—A Multiparametric Prediction
por: Muñoz-Martínez, Sergio, et al.
Publicado: (2023)

Mutational profile of skin lesions in hepatocellular carcinoma patients under tyrosine kinase inhibition: a repercussion of a wide-spectrum activity
por: da Fonseca, Leonardo G., et al.
Publicado: (2021)

Controversies in the management of hepatocellular carcinoma
por: Forner, Alejandro, et al.
Publicado: (2019)

Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents
por: Sanduzzi-Zamparelli, Marco, et al.
Publicado: (2019)

miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
por: de la Cruz-Ojeda, Patricia, et al.
Publicado: (2022)

Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma
por: Tutusaus, Anna, et al.
Publicado: (2018)

The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases
por: Sanduzzi Zamparelli, Stefano, et al.
Publicado: (2023)

Nasopharyngeal and Oropharyngeal Swabs, And/Or Serology for SARS COVID-19: What Are We Looking For?
por: Sanduzzi, Alessandro, et al.
Publicado: (2020)

Systemic therapy for hepatocellular carcinoma: trial enrichment does not guarantee success
por: Da Fonseca, Leonardo G., et al.
Publicado: (2018)

Restoring miR122 in human stem-like hepatocarcinoma cells, prompts tumor dormancy through Smad-independent TGF-β pathway
por: Boix, Loreto, et al.
Publicado: (2016)

Correlation between clinical-functional parameters and number of lobes involved in non-cystic fibrosis bronchiectasis
por: Giacon, Valeria, et al.
Publicado: (2021)

Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study
por: Cossiga, Valentina, et al.
Publicado: (2022)

Portal Hypertension may Influence the Registration of Hypointensity of Small Hepatocellular Carcinoma in the Hepatobiliary Phase in Gadoxetic Acid MR
por: Caparroz, Carla, et al.
Publicado: (2022)

Role of drug-dependent transporter modulation on the chemosensitivity of cholangiocarcinoma
por: Urtasun, Nerea, et al.
Publicado: (2017)

The success of regorafenib in hepatocellular carcinoma in a world of failures. Learnings for future developments
por: Reig, Maria, et al.
Publicado: (2017)

Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models
por: Cucarull, Blanca, et al.
Publicado: (2020)

Alpha-1-Antitrypsin Deficiency and Bronchiectasis: A Concomitance or a Real Association?
por: Sanduzzi, Alessandro, et al.
Publicado: (2020)

Association between COVID-19 and Sick Leave for Healthcare Workers in a Large Academic Hospital in Southern Italy: An Observational Study
por: Palladino, Raffaele, et al.
Publicado: (2022)

Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma
por: Soria, Anna, et al.
Publicado: (2022)

A Service-Constrained Positioning Strategy for an Autonomous Fleet of Airborne Base Stations
por: José-Torra, Ferran, et al.
Publicado: (2018)

A Phase II Study on the Effect of Taurisolo(®) Administered via AEROsol in Hospitalized Patients with Mild to Moderate COVID-19 Pneumonia: The TAEROVID-19 Study
por: Sanduzzi Zamparelli, Stefano, et al.
Publicado: (2022)

Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis
por: Lederer, Sharon L, et al.
Publicado: (2006)

Description of a new rare alpha-1 antitrypsin mutation in Naples (Italy): PI*M S-Napoli
por: Mosella, Marco, et al.
Publicado: (2018)

May Polyphenols Have a Role Against Coronavirus Infection? An Overview of in vitro Evidence
por: Annunziata, Giuseppe, et al.
Publicado: (2020)

Dermatological Manifestations in the Intensive Care Unit: A Practical Approach
por: Badia, Mariona, et al.
Publicado: (2020)

La muerte de Durruti
por: Llarch, Juan
Publicado: (1973)

New Challenges in the Management of Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy
por: Mauro, Ezequiel, et al.
Publicado: (2023)

Los delitos contra la hacienda pública : bien jurídico y tipos legales /
por: Boix Reig, Javier
Publicado: (1987)

El minusválido físico y su entorno : reflexiones psicoanáliticas
por: Reig Corominas, Ramón, 1903-1963
Publicado: (1995)

The pituitary tumour‐transforming gene 1/delta‐like homologue 1 pathway plays a key role in liver fibrogenesis
por: Perramón, Meritxell, et al.
Publicado: (2022)

Adult immunization with 13-valent pneumococcal vaccine in Campania region, South Italy: An economic evaluation
por: Liguori, Giorgio, et al.
Publicado: (2014)

CORRELATIONS BETWEEN VIRAL LOAD AND SYMPTOMS IN PATIENTS WITH COVID-19 PNEUMONIA
por: CAPITELLI, L., et al.
Publicado: (2022)

Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
por: Pinyol, Roser, et al.
Publicado: (2019)

A cost savings analysis of asynchronous teledermatology compared to face-to-face dermatology in Catalonia
por: Vidal-Alaball, Josep, et al.
Publicado: (2018)

Narrative medicine educational project to improve the care of patients with chronic obstructive pulmonary disease
por: Cappuccio, Antonietta, et al.
Publicado: (2018)

Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action
por: Pace, Elisabetta, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio predicts survival in European patients with hepatocellular carcinoma administered sorafenib
por: Lué, Alberto, et al.
Publicado: (2017)

Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma
por: Zhu, Zhenfeng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qid060ler3li39l6nu7er0ptu1